Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer Risk
100%
Prostate-specific Antigen
100%
Prostate-specific Antigen Testing
100%
Randomized Clinical Trial
100%
Low Intensity
100%
Screening Interventions
100%
Intervention Group
85%
Prostate Cancer
57%
Rate Ratio
42%
Gleason Grading
28%
Instrumental Analysis
28%
All-cause Mortality
28%
No Significant Difference
14%
Cancer Cases
14%
Overtreatment
14%
Prostate-specific Antigen Level
14%
Quality of Life
14%
Prostate
14%
Poor Prognosis
14%
Prostate Cancer Screening
14%
Cluster Randomized Trial
14%
United Kingdom
14%
Causal Effect
14%
Prostate Biopsy
14%
High-score
14%
Diagnostic Pathway
14%
Low-risk Prostate Cancer
14%
Cancer Stage
14%
Cancer Tumor
14%
Population Screening
14%
Overdetection
14%
Primary Care Practice
14%
P 50
14%
Screening Clinic
14%
Rate Difference
14%
Patient Follow-up
14%
Medicine and Dentistry
Cancer Mortality
100%
Prostate Specific Antigen
100%
Prostate Cancer
100%
Randomized Clinical Trials
100%
Median Follow Up
27%
Gleason Score
18%
All Cause Mortality
18%
Instrumental Variable Analysis
18%
Specific Mortality
18%
Cancer Staging
9%
Quality of Life
9%
Primary Health Care
9%
Prostate Specific Antigen Test
9%
Cluster Randomized Trial
9%
Cancer Screening
9%
Prostate Biopsy
9%
Tumor
9%
Nursing and Health Professions
Cancer Mortality
100%
Prostate Cancer
100%
Prostate Specific Antigen
100%
Clinical Trial
100%
Rate Ratio
27%
Gleason Score
18%
All Cause Mortality
18%
Instrumental Variable Analysis
18%
Cancer Staging
9%
Primary Medical Care
9%
Prostate Biopsy
9%
Cancer Screening
9%
Randomization
9%
Primary Health Care
9%
Standard of Practice
9%
Quality of Life
9%
Adherence
9%
Psychology
Prostate Cancer
100%
Clinical Trial
100%
Quality of Life
9%
Biopsy Technique
9%